test

Stuart Evan Seropian MD

Associate Professor of Medicine (Hematology)

Clinical Interests

Hodgkin's disease; Non-Hodgkin's Lymphoma (NHL); multiple myeloma; bone marrow transplant; stem cell transplant


Board Certifications

1997
Medical Oncology, Board Certified

Patient Care Locations

stuart_seropianfaculty-clinicsfalsetruetrue6truefalsefalse

Clinical Trials

ConditionsStudy Title
Hepatic Veno-Occlusive Disease, Hodgkin's Lymphoma, Leukemia, not otherwise specified, Multiple Myeloma, and Non-Hodgkin's LymphomaDefibrotide for Patients with Hepatic Veno-Occlusive Disease (VOD): A Treatment IND Study
Limited-stage Diffuse Large B-Cell Lymphoma and Non-Hodgkin's LymphomaA Phase II Trial of PET-Directed Therapy for Limited Stage Diffuse Large B-cell Lymphoma (SWOG S1001)
Myeloid and Monocytic LeukemiaA Randomized Phase III Study of Standard Cytarabine Plus Daunomycin (7+3) Therapy versus Idarubicin with High Dose Cytarabine (IA) with or without Vorinostat (IA+V) in Younger Patients with Previously Untreated Acute Myeloid Leukemia (AML)
Myeloid and Monocytic LeukemiaE2905: Randomized Phase III Trial Comparing the Frequency of Major Erythroid Response (MER) to Treatment with Lenalidomide (Revlimid) Alone and in Combination with Epoetin Alfa (Procrit) in Subjects with Low- or Intermediate-1 Risk MDS and Symptomatic Anemia
Leukemia, other(E1910) A Phase III Randomized Trial of Blinatumomab for Newly Diagnosed BCR-ABL-negative B lineage Acute Lymphoblastic Leukemia in Adults

More Clinical Trials...

Edit Profile